Liquidia Corp (LQDA): Next-Year EPS Estimate 70.10%
As of 2026-05-14, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 70.10%. Featured in 2 EPS revision reports, most recently on 2026-05-14.
On 2026-05-12, analyst consensus for LQDA's next-year EPS growth shifted from 88.60% to 70.10% — a negative change of 18.50 percentage points. The revised estimate has been sustained across 3 subsequent trading sessions. Current-year growth is projected at 518.56%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 70.10%
- EPS growth this year
- 518.56%
- EPS next quarter (est)
- $0.79
- Last price
- $59.30
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-14 | 70.10% | 518.56% | $0.79 | $59.30 |
| 2026-05-13 | 70.10% | 518.56% | $0.79 | $56.58 |
| 2026-05-12 | 70.10% | 518.56% | $0.79 | $56.60 |
| 2026-05-11 | 88.60% | 469.89% | $0.63 | $53.13 |
| 2026-05-10 | 95.50% | 436.22% | $0.41 | $42.30 |
| 2026-05-07 | 92.24% | 401.36% | $0.37 | $42.28 |
| 2026-05-06 | 92.24% | 401.36% | $0.37 | $42.14 |
| 2026-05-05 | 92.24% | 401.36% | $0.37 | $40.13 |
| 2026-05-04 | 92.24% | 401.36% | $0.37 | $38.48 |
| 2026-05-03 | 92.24% | 401.36% | $0.37 | $38.14 |
| 2026-04-30 | 92.24% | 401.36% | $0.37 | $39.21 |
| 2026-04-29 | 92.24% | 401.36% | $0.37 | $38.15 |
| 2026-04-28 | 92.24% | 401.36% | $0.37 | $37.65 |
| 2026-04-27 | 92.24% | 401.36% | $0.37 | $37.34 |
| 2026-04-26 | 92.24% | 401.36% | $0.37 | $37.31 |
| 2026-04-24 | 92.24% | 401.36% | $0.37 | $37.31 |
| 2026-04-23 | 92.24% | 401.36% | $0.37 | $37.46 |
| 2026-04-22 | 92.24% | 401.36% | $0.37 | $37.06 |
| 2026-04-21 | 92.24% | 401.36% | $0.37 | $36.25 |
| 2026-04-20 | 92.24% | 401.36% | $0.37 | $37.66 |
| 2026-04-19 | 92.24% | 401.36% | $0.37 | $39.47 |
| 2026-04-16 | 92.24% | 401.36% | $0.37 | $41.40 |
| 2026-04-15 | 92.19% | 401.43% | $0.37 | $40.12 |
| 2026-04-14 | 92.19% | 401.43% | $0.37 | $38.71 |
| 2026-04-13 | 92.19% | 401.43% | $0.37 | $38.85 |
| 2026-04-12 | 92.19% | 401.43% | $0.37 | $38.55 |
| 2026-04-10 | 92.19% | 401.43% | $0.37 | $38.91 |
| 2026-04-09 | 92.19% | 401.43% | $0.37 | $40.32 |
| 2026-04-08 | 92.19% | N/A | $0.37 | $38.19 |
| 2026-04-07 | 92.19% | N/A | $0.37 | $37.36 |
Reports Featuring LQDA
Screen Performance
Aggregate stats across all 1666 tickers our top-EPS-revision screen has flagged over the past 43 days.
- Median return since detection
- +4.0%
- % of tickers in the green
- 60%
- Median return on winners
- +16.0%
- Large revisions captured
- 552
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Liquidia Corp's next-year EPS growth estimate?▾
As of 2026-05-14, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 70.10%, based on analyst consensus.
When was the latest EPS estimate revision for LQDA?▾
The most recent revision occurred on 2026-05-12, when analysts adjusted the next-year EPS growth estimate from 88.60% to 70.10%.
What sector and industry does Liquidia Corp belong to?▾
Liquidia Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LQDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Liquidia Corp (LQDA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports